POSC
Price
$1.05
Change
+$0.10 (+10.53%)
Updated
Dec 17 closing price
RSMDF
Price
$24.08
Change
+$0.15 (+0.63%)
Updated
Dec 17 closing price
36 days until earnings call
Ad is loading...

POSC vs RSMDF

Header iconPOSC vs RSMDF Comparison
Open Charts POSC vs RSMDFBanner chart's image
Positron
Price$1.05
Change+$0.10 (+10.53%)
Volume$6.18K
CapitalizationN/A
Resmed
Price$24.08
Change+$0.15 (+0.63%)
Volume$100
CapitalizationN/A
POSC vs RSMDF Comparison Chart
Loading...
POSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RSMDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
POSC vs. RSMDF commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is POSC is a StrongBuy and RSMDF is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (POSC: $1.05 vs. RSMDF: $24.08)
Brand notoriety: POSC and RSMDF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: POSC: 61% vs. RSMDF: 13%
Market capitalization -- POSC: $442.55K vs. RSMDF: $32.67B
POSC [@Medical Specialties] is valued at $442.55K. RSMDF’s [@Medical Specialties] market capitalization is $32.67B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

POSC’s FA Score shows that 1 FA rating(s) are green whileRSMDF’s FA Score has 1 green FA rating(s).

  • POSC’s FA Score: 1 green, 4 red.
  • RSMDF’s FA Score: 1 green, 4 red.
According to our system of comparison, RSMDF is a better buy in the long-term than POSC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

POSC’s TA Score shows that 5 TA indicator(s) are bullish while RSMDF’s TA Score has 4 bullish TA indicator(s).

  • POSC’s TA Score: 5 bullish, 5 bearish.
  • RSMDF’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both POSC and RSMDF are a good buy in the short-term.

Price Growth

POSC (@Medical Specialties) experienced а -6.25% price change this week, while RSMDF (@Medical Specialties) price change was -1.62% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.17%. For the same industry, the average monthly price growth was +1.60%, and the average quarterly price growth was -0.66%.

Reported Earning Dates

RSMDF is expected to report earnings on Jan 23, 2025.

Industries' Descriptions

@Medical Specialties (-4.17% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RSMDF($32.7B) has a higher market cap than POSC($443K). RSMDF has higher P/E ratio than POSC: RSMDF (37.59) vs POSC (0.09). RSMDF YTD gains are higher at: 54.164 vs. POSC (-33.121). RSMDF has higher annual earnings (EBITDA): 1.31B vs. POSC (-699K). RSMDF has more cash in the bank: 228M vs. POSC (28K). POSC has less debt than RSMDF: POSC (962K) vs RSMDF (1.72B). RSMDF has higher revenues than POSC: RSMDF (4.02B) vs POSC (1.24M).
POSCRSMDFPOSC / RSMDF
Capitalization443K32.7B0%
EBITDA-699K1.31B-0%
Gain YTD-33.12154.164-61%
P/E Ratio0.0937.590%
Revenue1.24M4.02B0%
Total Cash28K228M0%
Total Debt962K1.72B0%
FUNDAMENTALS RATINGS
POSC vs RSMDF: Fundamental Ratings
POSC
RSMDF
OUTLOOK RATING
1..100
8790
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
18
Undervalued
PROFIT vs RISK RATING
1..100
4160
SMR RATING
1..100
10041
PRICE GROWTH RATING
1..100
8137
P/E GROWTH RATING
1..100
10056
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RSMDF's Valuation (18) in the null industry is in the same range as POSC (24). This means that RSMDF’s stock grew similarly to POSC’s over the last 12 months.

POSC's Profit vs Risk Rating (41) in the null industry is in the same range as RSMDF (60). This means that POSC’s stock grew similarly to RSMDF’s over the last 12 months.

RSMDF's SMR Rating (41) in the null industry is somewhat better than the same rating for POSC (100). This means that RSMDF’s stock grew somewhat faster than POSC’s over the last 12 months.

RSMDF's Price Growth Rating (37) in the null industry is somewhat better than the same rating for POSC (81). This means that RSMDF’s stock grew somewhat faster than POSC’s over the last 12 months.

RSMDF's P/E Growth Rating (56) in the null industry is somewhat better than the same rating for POSC (100). This means that RSMDF’s stock grew somewhat faster than POSC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
POSCRSMDF
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
25%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
30%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
38%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
23%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
41%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
31%
Advances
ODDS (%)
Bullish Trend 16 days ago
67%
N/A
Declines
ODDS (%)
Bearish Trend 7 days ago
83%
N/A
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
88%
Bearish Trend 2 days ago
25%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
N/A
View a ticker or compare two or three
Ad is loading...
POSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RSMDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LNGZX36.970.36
+0.98%
Columbia Greater China Inst
PAAEX17.86-0.06
-0.33%
Putnam Dynamic Asset Allocation Bal R6
BRGIX112.32-0.53
-0.47%
Bridges Investment Fund
PUGCX13.73-0.07
-0.51%
Putnam Focused International Equity C
OMGCX25.98-0.24
-0.92%
JPMorgan Mid Cap Growth C

POSC and

Correlation & Price change

A.I.dvisor tells us that POSC and SLDX have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that POSC and SLDX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To POSC
1D Price
Change %
POSC100%
+10.53%
SLDX - POSC
27%
Poorly correlated
N/A
GMED - POSC
20%
Poorly correlated
+2.11%
RSMDF - POSC
9%
Poorly correlated
+0.63%
RSCF - POSC
8%
Poorly correlated
-0.23%
PFGTF - POSC
7%
Poorly correlated
N/A
More

RSMDF and

Correlation & Price change

A.I.dvisor tells us that RSMDF and NAOV have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RSMDF and NAOV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RSMDF
1D Price
Change %
RSMDF100%
+0.63%
NAOV - RSMDF
30%
Poorly correlated
+5.30%
RMD - RSMDF
20%
Poorly correlated
+0.66%
PFGTF - RSMDF
19%
Poorly correlated
N/A
POSC - RSMDF
9%
Poorly correlated
+10.53%
SAFLF - RSMDF
9%
Poorly correlated
N/A
More